logo
logo

Durin Technologies, Inc. announced it raised $3.5 Million in an initial filing from an offering of $3.5 Million

Mar 23, 2021over 4 years ago

Amount Raised

$3.5 Million

Round Type

seed

Mullica HillBiotechnology

Company Information

Company

Durin Technologies, Inc.

Location

107 GILBRETH PARKWAY

Mullica Hill, New Jersey, United States

About

Durin Technologies develops non-invasive, easy access diagnostic tests for the most prevalent and devastating neurodegenerative disorders, including Alzheimer's and Parkinson's diseases.​ Its rapid-result, high-accuracy DuritectTM diagnostic tests make early detection and monitoring of disease progression possible – in a decade or more prior to symptoms in some cases. Durin’s first two tests – for Alzheimer's and Parkinson’s – will come to market in 2024, followed by tests for other diseases.​ The company’s groundbreaking science creates a scalable platform for diagnostic tests that will extend beyond the multi-billion-dollar neurodegenerative diagnostics market into the much larger, broader disease diagnostic market.​

Related People